CCEP stock forecast, quote, news & analysis

CCEP sees MACD Histogram crosses below signal line

CCEP saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 27, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In 21 of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 45%.

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCEP as a result. In 36 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 36%.

CCEP moved below its 50-day moving average on September 04, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CCEP crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 24%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCEP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 37%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CCEP's RSI Oscillator exited the oversold zone, 12 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEP advanced for three days, in 191 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.

CCEP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.630) is normal, around the industry mean (6.850). P/E Ratio (19.592) is within average values for comparable stocks, (43.449). Projected Growth (PEG Ratio) (2.634) is also within normal values, averaging (3.711). Dividend Yield (0.024) settles around the average of (0.013) among similar stocks. P/S Ratio (1.873) is also within normal values, averaging (2.785).

The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. CCEP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

CCEP paid dividends on December 06, 2021